drug
landiolol hydrochloride
Marketedupdated 3mo agoby AOP Health
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1indications
investigational
Atrial Fibrillation
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 13, 2029
~2.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Apr 25, 2034method-of-use (U-4235)US 10722516
FDA exclusivities (2)
- Nov 22, 2029NCENew Chemical Entity (5y)3.3y
- Feb 13, 2029NPPNew Product (3y)2.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 29m ago
Found something off?
comments(0)
5-min edit window · permanent after that